ALS Variants of Annexin A11's Proline-Rich Domain Impair Its S100A6-Mediated Fibril Dissolution.
Intrinsically disordered regions
NMR
SPR
amyloids
neurodegenerative diseases
phase separation
Journal
ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337
Informations de publication
Date de publication:
02 08 2023
02 08 2023
Historique:
medline:
3
8
2023
pubmed:
11
7
2023
entrez:
11
7
2023
Statut:
ppublish
Résumé
Mutations in the proline-rich domain (PRD) of annexin A11 are linked to amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, and generate abundant neuronal A11 inclusions by an unknown mechanism. Here, we demonstrate that recombinant A11-PRD and its ALS-associated variants form liquidlike condensates that transform into β-sheet-rich amyloid fibrils. Surprisingly, these fibrils dissolved in the presence of S100A6, an A11 binding partner overexpressed in ALS. The ALS variants of A11-PRD showed longer fibrillization half-times and slower dissolution, even though their binding affinities for S100A6 were not significantly affected. These findings indicate a slower fibril-to-monomer exchange for these ALS variants, resulting in a decreased level of S100A6-mediated fibril dissolution. These ALS-A11 variants are thus more likely to remain aggregated despite their slower fibrillization.
Identifiants
pubmed: 37433222
doi: 10.1021/acschemneuro.3c00169
pmc: PMC10401653
doi:
Substances chimiques
Annexins
0
Amyloid
0
Proline
9DLQ4CIU6V
S100A6 protein, human
105504-00-5
S100 Calcium Binding Protein A6
0
Cell Cycle Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2583-2589Références
Proteins. 2005 Jun 1;59(4):687-96
pubmed: 15815974
J Biol Chem. 2018 Sep 21;293(38):14850-14867
pubmed: 30087119
Angew Chem Int Ed Engl. 2014 Jan 20;53(4):1025-8
pubmed: 24338988
Biochemistry. 2021 Aug 24;60(33):2519-2523
pubmed: 34342986
J Biol Chem. 2021 Nov;297(5):101328
pubmed: 34688656
J Am Chem Soc. 2013 Oct 30;135(43):16133-47
pubmed: 24066695
J Biol Chem. 1992 May 5;267(13):8919-24
pubmed: 1533622
J Biol Chem. 1998 Mar 13;273(11):6351-7
pubmed: 9497364
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12456-12461
pubmed: 27791180
Phys Chem Chem Phys. 2015 Mar 28;17(12):7606-18
pubmed: 25719972
J Am Chem Soc. 2023 Apr 12;145(14):7748-7752
pubmed: 37010382
Biophys Chem. 2010 Oct;151(3):181-6
pubmed: 20621410
Structure. 2002 Apr;10(4):557-67
pubmed: 11937060
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3374-9
pubmed: 25713345
Sci Transl Med. 2017 May 3;9(388):
pubmed: 28469040
J Neuropathol Exp Neurol. 2002 Aug;61(8):736-44
pubmed: 12152788
ACS Appl Mater Interfaces. 2018 Nov 21;10(46):39505-39511
pubmed: 30346695
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24274-24284
pubmed: 32917811
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
J Biol Chem. 2003 May 30;278(22):20210-6
pubmed: 12601007
Curr Protoc Protein Sci. 2013 Feb;Chapter 20:Unit20.12
pubmed: 23377850
Protein Sci. 1997 Nov;6(11):2359-64
pubmed: 9385638
Sci Adv. 2023 Jul 14;9(28):eadg3913
pubmed: 37450591
Biochemistry. 2012 Mar 20;51(11):2224-31
pubmed: 22360139
Cell. 2019 Sep 19;179(1):147-164.e20
pubmed: 31539493
Structure. 2017 Aug 1;25(8):1195-1207.e5
pubmed: 28669632
Physiol Rev. 2002 Apr;82(2):331-71
pubmed: 11917092